Cargando…
HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin
The Epidermal Growth Factor Receoptor (EGFR) family member human epidermal growth factor receptor 2 (HER2) is overexpressed in many human epithelial malignancies, representing a molecular target for specific anti-neoplastic drugs. Few data are available on HER2 status in differentiated thyroid cance...
Autores principales: | Ruggeri, Rosaria M., Campennì, Alfredo, Giuffrè, Giuseppe, Giovanella, Luca, Siracusa, Massimiliano, Simone, Angela, Branca, Giovanni, Scarfì, Rosa, Trimarchi, Francesco, Ieni, Antonio, Tuccari, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187840/ https://www.ncbi.nlm.nih.gov/pubmed/27929428 http://dx.doi.org/10.3390/ijms17122040 |
Ejemplares similares
-
Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers
por: Campennì, Alfredo, et al.
Publicado: (2022) -
Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target
por: Trovato, Maria, et al.
Publicado: (2017) -
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic
por: Ruggeri, Rosaria Maddalena, et al.
Publicado: (2020) -
What is New on Thyroid Cancer Biomarkers
por: Ruggeri, Rosaria M., et al.
Publicado: (2008) -
BRAF-AXL-PD-L1 Signaling Axis as a Possible Biological Marker for RAI Treatment in the Thyroid Cancer ATA Intermediate Risk Category
por: Pizzimenti, Cristina, et al.
Publicado: (2023)